BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8675757)

  • 1. Antigenic crossreactivity and lipopolysaccharide neutralization properties of bovine immunoglobulin G.
    Tomita GM; Todhunter DA; Hogan JS; Smith KL
    J Dairy Sci; 1995 Dec; 78(12):2745-52. PubMed ID: 8675757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of dairy cows with an Escherichia coli J5 lipopolysaccharide vaccine.
    Tomita GM; Todhunter DA; Hogan JS; Smith KL
    J Dairy Sci; 1995 Oct; 78(10):2178-85. PubMed ID: 8598402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic homology among gram-negative organisms isolated from cattle with clinical mastitis.
    Tyler J; Spears H; Cullor J; Smith W; Nelson R; Martin J
    J Dairy Sci; 1991 Apr; 74(4):1235-42. PubMed ID: 1907303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
    Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperimmunization of steers with J5 Escherichia coli bacterin: effects on isotype-specific serum antibody responses and cross reactivity with heterogeneous gram-negative bacteria.
    Chaiyotwittayakun A; Burton JL; Weber PS; Kizilkaya K; Cardoso FF; Erskine RJ
    J Dairy Sci; 2004 Oct; 87(10):3375-85. PubMed ID: 15377616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intramammary immunization with an Escherichia coli J5 bacterin.
    Smith JL; Hogan JS; Smith KL
    J Dairy Sci; 1999 Dec; 82(12):2582-8. PubMed ID: 10629804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic activity of serum and whey from cows immunized with the ferric citrate receptor.
    Wise AJ; Hogan JS; Takemura K; Smith KL
    J Dairy Sci; 2003 Jan; 86(1):146-51. PubMed ID: 12613859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adjuvants on safety and efficacy of an Escherichia coli J5 bacterin.
    Hogan JS; Cannon VB; Smith KL; Rinehart C; Miller S
    J Dairy Sci; 2005 Feb; 88(2):534-42. PubMed ID: 15653518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine.
    González RN; Cullor JS; Jasper DE; Farver TB; Bushnell RB; Oliver MN
    Can J Vet Res; 1989 Jul; 53(3):301-5. PubMed ID: 2670166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth responses of Escherichia coli to immunoglobulin G from cows immunized with ferric citrate receptor, FecA.
    Takemura K; Hogan JS; Smith KL
    J Dairy Sci; 2004 Feb; 87(2):316-20. PubMed ID: 14762074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hyperimmunization with an Escherichia coli J5 bacterin in adult lactating dairy cows.
    Erskine RJ; VanDyk EJ; Bartlett PC; Burton JL; Boyle MC
    J Am Vet Med Assoc; 2007 Oct; 231(7):1092-7. PubMed ID: 17916037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an Escherichia coli J5 mastitis vaccine in an experimental challenge trial.
    Hogan JS; Weiss WP; Todhunter DA; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Feb; 75(2):415-22. PubMed ID: 1560136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an Escherichia coli J5 vaccine on mild clinical coliform mastitis.
    Hogan JS; Weiss WP; Smith KL; Todhunter DA; Schoenberger PS; Sordillo LM
    J Dairy Sci; 1995 Feb; 78(2):285-90. PubMed ID: 7745148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of cows with novel core glycolipid vaccine induces anti-endotoxin antibodies in bovine colostrum.
    Cross AS; Karreman HJ; Zhang L; Rosenberg Z; Opal SM; Lees A
    Vaccine; 2014 Oct; 32(46):6107-14. PubMed ID: 25242628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine.
    Hogan JS; Smith KL; Todhunter DA; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):78-84. PubMed ID: 1541745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an Escherichia coli J5 bacterin administered to primigravid heifers.
    Hogan JS; Bogacz VL; Aslam M; Smith KL
    J Dairy Sci; 1999 May; 82(5):939-43. PubMed ID: 10342231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of cows with ferric enterobactin receptor from coliform bacteria.
    Lin J; Hogan JS; Aslam M; Smith KL
    J Dairy Sci; 1998 Aug; 81(8):2151-8. PubMed ID: 9749380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of immunization with ferric citrate receptor FecA from Escherichia coli on induced coliform mastitis.
    Takemura K; Hogan JS; Lin J; Smith KL
    J Dairy Sci; 2002 Apr; 85(4):774-81. PubMed ID: 12018422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.